http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DO-P2012000148-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27a71ddaaa2f5a8c228fc6cb3f3b3098
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B65D75-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7052
filingDate 2012-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc50901c9780fcc8a902409079f3bc18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52bc4b367c5bb2ed579949ee7a1bde97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ded2a43cd91c5e9294f2f48165afe7c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ab26fed221c271e8c3477c64051d0d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa1e7aeafb125adea37016d776852df2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e827e1879c11451d2263d76a5edb6dff
publicationDate 2012-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DO-P2012000148-A
titleOfInvention COMBINATIONS OF AN ANTAGONIST OF MUSCARINIC RECEIVERS AND A BETA-2 ADRENO-RECEIVER AGONIST
abstract Novel combinations of an acetylcholine muscarinic receptor antagonist and a beta-2 agonist were provided for inhaled administration through the nose or mouth, and methods for use.
priorityDate 2009-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187

Total number of triples: 34.